Megmanox
Megmanox Products are primarily used for
Acute coronary syndrome, Blood clots, Deep vein thrombosis
About Megmanox Products
Uses of Megmanox Products
Enoxaparin is used in the treatment and prevention of acute coronary syndrome, blood clots, deep vein thrombosis and pulmonary embolism. It prevents the formation of blood clots in the legs, lungs, brain or heart.
Megmanox Products side effects
Common
Side Effects of Megmanox are Anemia (low number of red blood cells), Allergic reaction, Fever, Headache, Low blood platelets, Increased liver enzymes, Hemorrhage, Ecchymosis (discoloration of the skin resulting from bleeding underneath), Nausea, Edema (swelling), Shortness of breath, Confusion, Thrombocytosis, Skin disorder, Injection site reactions (pain, swelling, redness), Heart attack.
How Megmanox Products work
Enoxaparin is an anticoagulant. It works by inactivating certain blood-clotting proteins. This prevents the formation of blood clots and prevents blockages in the blood vessels of the body.
Patient Concerns about Megmanox Products
Frequently asked questions about Megmanox Products
Frequently asked questions about Enoxaparin
Q. What is Megmanox 40mg Injection used for?
Megmanox 40mg Injection is used to prevent and treat blood clots in conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE). It is also used in certain acute heart conditions, including unstable angina and heart attacks, to reduce the risk of serious clot-related complications.
Q. How is Megmanox 40mg Injection given?
Megmanox 40mg Injection is given as an injection under the skin (subcutaneous injection), usually in the abdomen. In some heart attack cases, an initial dose may be given into a vein, followed by injections under the skin.
Q. For how long will I need to take Megmanox 40mg Injection?
The duration of treatment depends on the condition being treated. For blood clots like DVT or PE, treatment usually lasts several days and may be followed by oral blood thinners. In heart conditions, it is generally used for a short period until the condition stabilises or hospital treatment is completed.
Q. Who should use Megmanox 40mg Injection with caution?
Megmanox 40mg Injection should be used carefully in people with kidney problems, a history of bleeding disorders, low platelet counts, or those taking other blood-thinning medicines. Dose adjustments and close monitoring may be required in elderly patients or those with reduced kidney function.
Products for Megmanox
Megmanox 40mg Injection
vial of 0.4 ml Injection
MRP
₹371.78
Megmanox 60mg Injection
vial of 0.6 ml Injection
MRP
₹557.67